News | Mobile Devices | August 24, 2018

Cerner and Duke Clinical Research Institute Collaborate on Cardiac Risk App

App presents vitals and lab measurements for cardiac risk patients to facilitate dialogue and help improve health outcomes

Cerner and Duke Clinical Research Institute Collaborate on Cardiac Risk App

August 24, 2018 — Cerner recently collaborated with Duke Clinical Research Institute (DCRI) to develop an atherosclerotic cardiovascular disease (ASCVD) Risk Calculator app. The app was designed as a tool to increase communication between the patient and their doctor about ways to live a healthier life and risk factors for heart disease and stroke.

The app helps healthcare providers estimate 10-year and lifetime ASCVD risk for patients based on information like age, race, sex, blood pressure, cholesterol levels, smoking and diabetes status. If untreated, ASCVD can lead to heart attack and sudden cardiac arrest, as well as fatal and nonfatal stroke. To facilitate shared decision-making between the patient and their doctor to guide treatment decisions, the app was designed to factor in a person’s willingness to take action to improve their health, and the risks and benefits of potential therapies.

“Guidelines from the American College of Cardiology and American Heart Association now emphasize using the 10-year calculator to identify adults for statin therapy,” said Pierre Elias, M.D., cardiology fellow at Columbia University and former medical student at Duke University School of Medicine. “We wanted an app that would make it easier for clinicians to calculate risk at the point of care. Whether it’s the primary care clinic or a cardiologist’s office, I can’t tell you the number of times this can get missed when there are so many other problems to manage. Making it faster and easier to get news you can use leads to better patient care.”

Cerner and DCRI worked together to develop the software through the Cerner Open Developer Experience (code) that encourages innovators to build apps that advance the healthcare industry. Through Cerner’s open source code, doctors from DCRI provided clinical direction to create an app that could be embedded within Cerner’s electronic health record (EHR) for each patient. Cerner wrote, maintains and hosts the ASCVD Risk Calculator under an open source license.

“We developed the app to be able to pull important patient health data across multiple EHR suppliers at different venues of care in order to get a full picture of how to improve that patient’s health,” said Ann Marie Navar, M.D., Ph.D., assistant professor of medicine (cardiology) at Duke University School of Medicine and member of the Duke Clinical Research Institute who led the collaboration. “Cerner’s open platform encourages collaboration, which will help advance the way care is delivered regardless of the specific platform people are using.”

The ASCVD Risk Calculator app is available to providers in the SMART App Gallery and the Cerner Open Developer Experience (code) App Gallery.

For more information: www.code.cerner.com


Related Content

News | Cardiac Diagnostics

February 9, 2023 — Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD ...

Home February 08, 2023
Home
News | Cardiac Diagnostics

September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...

Home September 15, 2022
Home
Feature | Cardiac Diagnostics | by Kelly Patrick

Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 ...

Home August 23, 2022
Home
Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
Home
News | Cardiac Diagnostics

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

Home January 31, 2022
Home
News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Feature | Cardiac Diagnostics | By Dave Fornell, DAIC Editor

October 29, 2021 — A new guideline for the evaluation and diagnosis of chest pain was released this week that provides ...

Home October 29, 2021
Home
News | Cardiac Diagnostics

October 4, 2021 – Nanowear, a hospital-at-home and remote diagnostic platform that used proprietary wearable cloth ...

Home October 04, 2021
Home
News | Cardiac Diagnostics

September 28, 2021 — Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a ...

Home September 28, 2021
Home
News | Cardiac Diagnostics

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation ...

Home July 29, 2021
Home
Subscribe Now